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diagnosed for less than three weeks), and four healthyRetroviral Superantigens and Type 1
adult controls. All subjects were of Caucasoid extrac-Diabetes Mellitus tion. RT-PCRs, with the Conrad et al. (1997) protocol
and reagents, generated a band of the expected size
(489 bp) for IDDMK1,222 with U3-R-poly(A) primer fromIn 1994, Conrad et al. reported initial results that rekin-
all samples, but in both the presence and absence of
dled the debate about the involvement of an infectious
RT. The U3-R-poly(A) primer also generated a 489 bp
agent in type 1 diabetes. They analyzed the T cell (anti-
band from genomic DNA samples. The RT-PCR product
gen) receptor repertoire of T lymphocytes that had in-
hybridized with the U3-R probe, as reported by Conrad
vaded the pancreatic islets of two recently deceased,
et al. (1997). However, DNase treatment of the RNA
acutely diabetic patients. Antigen receptors carrying
samples prevented generation of the PCR product and
the Vb7 variable region were shown to be strikingly en- its detection by Southern blot. We could not achieve
riched in the T cells, evoking the involvement of a super- specificity for RNA, by extending 59 the U3-R-poly(A)
antigen (SAG). Recently, Conrad et al. (1997) (see also primer from four to 11Ts and/or by subtracting eight of
Benoist and Mathis, 1997) described the isolation of a the 39 nucleotides, whereas the Pittsburgh and London
hitherto unknown endogenous HERV-K10-like retroviral laboratories (see below) detected viral RNAs with modi-
genome, IDDMK1,222, related to mouse mammary tumor fied primers, although these were also not disease spe-
virus, whose env gene encoded a SAG. The SAG stimu- cific. It should be noted, however, that the various modi-
lated Vb7-bearing T cells, but not those that expressed fied primers were not identical.
other Vb genes. Transcripts derived from, or at least Conrad et al. (1997) added RT and PCR reagents to
related to, the IDDMK1,222 genome were detectable the same reaction tube. When we added the PCR re-
by RT-PCR in the plasma of 10/10 newly diagnosed type 1 agents after the RT reactions, the yield of the U3-R-
diabetes patients, but not from 10 age-matched, nondia- poly(A) product significantly increased, but again it was
betic control individuals. In order to detect IDDMK1,222 not specific for RNA. The increased yield was most likely
RNA, Conrad et al. (1997) performed RT-PCR on total due to separation of Pwo, a DNA polymerase with 39±59
RNA purified from EDTA plasma using QIAmp Qiagen exonuclease proofreading activity, from the RT reaction.
Kit. All RT and PCR reagents (1 unit AMV reverse tran- Pwo could degrade primers and dNTPs during the RT
scriptase, 10 units Rnasin, 0.5 mM DTT, 2.6 units Taq/ section, resulting in a lower yield of PCR product. Finally,
Pwo, 0.2 mM dNTPs, 300 nM primers, 13 buffer, and we made primers to the SAG sequence of IDDMK1,222
1.6 mM MgCl2) were added to the same reaction tube. and found also that these amplified only genomic DNA
The RT reaction was performed at 508C for 30 min for and not DNase-treated RNA samples.
the generation of cDNA, directly followed by a step- Thus, we have not been able to confirm the statement
down PCR, in which the annealing temperature (688C) of Conrad et al. (1997) that ªthe signal generated with
was reduced by 1.38C for each of 10 cycles, to 558C for the U3-R-poly(A) primer pair could be diminished below
the remaining 25 cycles. Two sets of oligonucleotide background by RNase treatment and was not detected
primers were used: U3 (59 AGGTATTGTCCAAGGTTTC when genomic DNA was used as a template (data not
TCC 39) and R (59 CTTTACAAAGCAGTATTGCTG 39 or shown).º In our hands, the U3-R-poly(A) primer pair does
59 GTAAAGGATCAAGTGCTGTGC 39) or U3-R-poly(A) not detect transcribed IDDMK1,222 endogenous retrovi-
(59 TTTTTGAGTCCCCTTAGTATTTATT 39). They stated rus in EDTA plasma. All PCR product from plasma RNA
that the U3 and R primers detected genomic IDDMK1,222, appears to derive from contaminating DNA and is not
whereas U3 and R-poly(A) primers detected only viral type 1 diabetes (preclinical or clinical)-specific. Our re-
transcripts. In an attempt to reproduce these latter data, sults do not, however, necessarily refute the proposition
we report here the results of experiments carried out that endogenous retroelements, identical or similar to
independently in laboratories in Melbourne, Pittsburgh, IDDMK1,222, might encode a SAG responsible for skew-
and London. It must be emphasized that the three labo- ing of the T cell receptor Vb repertoire in the islet infiltrate
ratories only attempted to reproduce and extend the of the type 1 diabetes patients as reported by Conrad
results of Conrad et al. (1997) on peripheral blood and et al. (1997).
not those on the isolation of retroviral particles from In Pittsburgh, in order to extend the results of Con-
islets and islet-infiltrating lymphocytes from patients rad et al. (1997), we designed primers that amplify the
with type 1 diabetes. sequence encoding the reported superantigen of
In Melbourne, we used the exact protocol of Conrad IDDMK1,222. The sequences of the primers, CCTCCACG
et al. (1997), or modified protocols, to confirm that GAGATGGTAA and TCGAGGTGCCTAATCTATAATAGT,
IDDMK1,222 transcripts are present in the plasma of indi- matched the sequence in the region of the ATG and
viduals with preclinical or clinical type 1 diabetes. We TAG, start and stop codons, and were first tested on
purified total RNA from EDTA plasma of two individuals genomic DNA. Cloning and sequencing of the amplified
with preclinical type 1 diabetes (a male aged 7 and a products yielded eight unique sequences from nine
female aged 18, each of whom had a sibling with type 1 clones, one of which was identical to the reported SAG.
diabetes and circulating antibodies to the islet antigens, We then tested, by RT-PCR, RNA extracted from sera
insulin and glutamic acid decarboxylase [GAD]), three and EDTA plasma and peripheral blood lymphocytes
(PBL) of five Caucasoid high-risk individuals (siblings ofrecently-diagnosed patients (females age 5, 9, and 10,
Cell
10
diabetic probands, carrying type 1 diabetes susceptibil- Subsequently, the U3-R-poly(A) primer amplified the
expected product of 489 bp by RT-PCR on RNA ex-ity HLA class II alleles, positive for autoantibodies to the
islet antigens GAD65 and tyrosine phosphatase IA-2, tracted from PBL of four out of five newly diagnosed
patients. However, ribonuclease A treatment did notand with impaired glucose tolerance), ten recent-onset
type 1 diabetes patients (within one week of clinical prevent amplification, suggesting the presence of DNA
contamination in the samples. Ribonuclease treatmentdiagnosis) and 12 age-matched nondiabetic controls.
Thus, our tested samples came from patients at the eliminated the RT-PCR product from positive control
RNA (supplied in Access RT-PCR Kit, cat. no 1260, Pro-same stage of their disease as those tested by Conrad
et al. (1997). Poly(A)-RNA was separated from total RNA mega, USA).
The U3-R-poly(A) primer also amplified a product ofthat had first been treated with DNase. It was then re-
verse transcribed using the R-poly(A) primer described 489 bp, using the same PCR conditions, but without the
RT step, on DNA extracted from the same PBL of newlyby Conrad et al. (1997). After PCR amplification using
the above primers, bands of 489 bp were frequently, diagnosed patients. When an RNA sample positive in
RT-PCR with the U3-R-poly(A) primers was pretreatedthough not always, found in patient samples (100% of
high-risk individuals and 50% of recent-onset patients). with RNase-free DNase, the 489 bp product was elimi-
nated. With the same conditions, it was still possibleMost importantly, however, they were also found in
seven out of twelve (58%) of control samples. Cloning to obtain amplification from the positive control RNA,
showing that the elimination of the signal was not dueand sequencing of the PCR products revealed two domi-
nant sequences, present in some samples from both to RNase contaminating the DNase. Hence, in our hands,
the U3-R-poly(A) primer amplified DNA and we suggestpatients and controls, which were very similar to HERV-
K10 and to IDDMK1,222. These sequences mismatched that the amplification we observed in our RT-PCR sam-
ples was due to trace contamination of DNA.HERV-K10 by 8 and 4 nucleotides and IDDMK1,222 by 8
and 13 nucleotides. None of the clones contained a The same RT-PCR conditions were used with the U3
primer and a novel viral RNA-specific oligo-dT primersequence that exactly matched the IDDMK1,222 se-
quence. When the PCR was performed with either of of the sequence 59±39 TTTTTTTTTTTTTTTTTTTTGA
GTC. A product of approximately 489 bp size was ob-two alternative primers, which are downstream of the
stop codon, TCCCAAGGGTAGAAAGACTG and the U3- tained with RNA from two out of three PBL samples
from newly diagnosed patients and was eliminated byR-poly(A) primer, the same two sequences were again
most frequent. In addition, they were found to not en- ribonuclease treatment. In order to confirm specificity
for RNA, PCR was performed without the RT step andcode the stop codon characteristic of IDDMK1,222, but
rather the same codon, TGG, which is present in HERV- was negative on DNA from the same PBL. The same RT-
PCR conditions were also applied using the U3 primerK10. Again, none of the other less frequently obtained
clones matched exactly the IDDMK1,222 sequence. together with a long oligo dT primer [59 pd(T)25±30 39].
A product of approximately 489 bp was again obtainedThus, based on the amplification of purified genomic
DNA, we confirmed the presence of an endogenous with the same PBL RNA from two out of three newly
diagnosed patients. PCR performed on DNA in the samesequence matching that which would encode the re-
ported superantigen. However, if the corresponding conditions, but without the RT step, detected a product
of the same size in one out of five samples of newlyRNA is expressed, it is frequently not the most abun-
dantly expressed HERV-K10-like species and, therefore, diagnosed patients. This sample was also positive in RT-
PCR and possibly contains an integrated (endogenous)may not easily be detected in the presence of the other
more abundant sequences. Furthermore, these very retrovirus with poly(A) tail. When RNA from PBL of nor-
mal individuals were analyzed, with either the U3-oligosimilar sequences are not specifically expressed in type
1 diabetes, as they are frequently detected in control dT virus±specific primer or the oligo dT 25±30 primer,
products of approximately 489 bp were obtained in twosamples. We do not interpret these findings to necessar-
ily negate a potential etiological role of retroviruses or of three and three of three cases, respectively; i.e., the
product, in this case, was not disease specific.superantigens in type 1 diabetes, rather to question the
epidemiologic value of nonspecific retroviral sequence In summary, our experiments indicate that the U3-R-
poly(A) primers described by Conrad et al. (1997) aredetection in patients' plasma.
In London, we initially performed survey studies, by not RNA specific, but also amplify DNA, and we could
detect viral RNA sequences in both newly diagnosedmeans of genomic PCR and RT-PCR based on the pub-
lished primer sequences from the IDDMK1,222 novel ret- type 1 diabetes patients and normal controls using our
modified RNA-specific primers.roviral genome. Genomic DNA was subjected to PCR
with the U3 and R primers. Primers U3 R1 and U3 R2 RNA transcripts for multiple endogenous retroviral
elements are expressed in normal and disease tissuesamplified products of the size described by Conrad et
al. (1997) (300 and 395 bp) on DNA samples extracted (Nakagawa et al., 1997). The genomic complexity and
multiple potential pathogenic mechanisms of endoge-from PBL of 10 age-matched normal individuals and five
newly diagnosed (within one week of clinical onset) type nous retroviruses (Nakagawa and Harrison, 1996) sug-
gest that experimental strategies will need to be re-1 diabetes patients. The patients, two Caucasoids and
three Africans, were sero-positive for islet cell antibod- fined, in order to unravel their possible involvement in
the pathogenesis of type 1 diabetes (Bottazzo, 1993).ies (ICA), by indirect immunofluorescence on sections
of human blood group 0 pancreas, and for antibodies We are unable to confirm that the strategy of Conrad
et al. (1997) identifies type 1 diabetes±specific, novelto GAD and tyrosine phosphatase IA-2, and all carried
type 1 diabetes susceptibility HLA class II alleles. IDDMK1,222 retroviral RNA in plasma.
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Vincent J. Murphy and Leonard C. Harrison patients. Here we present findings contradicting this
intriguing hypothesis.Autoimmunity and Transplantation Division
The Walter and Eliza Hall The Endogenous IDDMK1,2 22 Provirus
Is Not a Novel RetrovirusInstitute of Medical Research
Royal Melbourne Hospital HERV-K is an endogenous retrovirus family of old world
monkeys and humans with homologies to type B andParkville 3050
Australia D retroviruses. Within the approximately 50 proviral cop-
ies of this HERV family only very few of the full-length
William A. Rudert, Patrizia Luppi, genomes (designated type 2) have retained colinear
coding capacity. As this HERV family codes for the hu-and Massimo Trucco
Division of Immunogenetics man teratocarcinoma-derived retrovirus (HTDV), it was
tentatively designated HTDV/HERV-K to discriminate itDepartment of Pediatrics
University of Pittsburgh from other MMTV-related HERV families with primer-
binding sites for tRNA lysine (HERV-K). A subclass ofSchool of Medicine and Children's Hospital
Pittsburgh, Pennsylvania 15213 HTDV/HERV-K proviruses (type 1) is characterized by a
deletion affecting the C terminus of the integrase domain
Alessandra Fierabracci, Paul Andrew Biro, and the amino terminus of the envelope (Env), the signal
peptide region (reviewed by LoÈ wer et al., 1996). Theand Gian Franco Bottazzo*²
Department of Immunology deletion also eliminates the first exon of the corf gene,
an accessory gene that enhances the expression ofSt Bartholomew's and the Royal London
School of Medicine and Dentistry structural proteins. This function is lacking in cell types
in which only type 1 proviruses are expressed. In addi-Turner Street, London E1 2AD
United Kingdom tion, many type 1 proviruses do not exhibit env splicing
(LoÈ wer et al., 1995). Most of the HTDV/HERV-K provi-*The Autoimmune Diseases Charitable Trust
28 Glenilla Road ruses carry stop codons in their env genes preventing
expression of functional Env proteins. Sequence com-London NW3 4AN
United Kingdom parison clearly shows that the truncated IDDMK1,222 env
sequence identified by Conrad et al. stems from one of
these proviruses. It is a type 1 element similar to theReferences
proviruses K10 and K18 described previously (Ono, 1986).
Benoist, C., and Mathis, D. (1997). Nature 388, 833±834. The sequence information available for IDDMK1,2 shows
Bottazzo, G.F. (1993). Diabetes 42, 778±780. a 3% difference to K10 in env and in the long terminal
repeats (LTRs), the most variable regions of a virus, andConrad, B., Weidmann, E., Trucco, G., Rudert, W.A., Behboo, R.,
Ricordi, C., Rodriquez-Rilo, H., Finegold, D., and Trucco, M. (1994). a near identity to the LTRs of K18. In summary Conrad
Nature 371, 351±355. et al. have identified one of the proviruses of a well-
Conrad, B., and Trucco, M. (1994). Diab. Metab. Rev. 10, 309±338. studied HERV family.
Conrad, B., Weissmahr, R.N., Boeni, J., Arcari, R., Schuepbach, J., There Is No Evidence that the RT Activity Detected
and Mach, B. (1997). Cell 90, 303±313. in the Supernatant of IDDM Islets Originated
Nakagawa, K., and Harrison, L.C. (1996). Immunol. Rev. 152, 193±236. from the IDDMK1,2 22 Provirus
Nakagawa, K., Brusic, V., McColl, G., and Harrison, L.C. (1997). In human teratocarcinoma cell lines, it is easy to detect
Arthritis Rheum. 40, 627±638. virus particles by electron microscopy or viral transcripts
by Northern blots (Figure 1) although the level of expres-
² To whom correspondence should be addressed. Present address: sion is significantly lower than that seen with exogenous
Ospedale Pediatrico Bambino GesuÂ , Scientific Institute, Direzione
retroviruses. To measure reverse transcriptase activity,Scientifica, via Piazza S Onofrio, 4, 00165 Roma, Italy.
concentration of particles by ultracentrifugation is re-
quired for even the most sensitive of assays. A simple
explanation may be that many HTDV/HERV-K proviralDevelopment of Insulin-Dependent
RT genes do not code for enzymatically active proteins
Diabetes Mellitus Does Not Depend when studied in recombinant expression systems (ToÈ njes
et al., 1996). HTDV/HERV-K sequences only are de-on Specific Expression of the Human
tected in RNA isolated from HTDV particle preparationsEndogenous Retrovirus HERV-K (Simpson et al., 1996).
Although no evidence for the physical presence of
Insulin-dependent diabetes mellitus (IDDM) is a b cell± particles or of virus transcripts is presented, Conrad
specific, T cell±mediated autoimmune disease. Last year, et al. also describe a low level of RT activity in the
Bernard Conrad and coworkers proposed that the b supernatant of cell lines derived from IDDM islets with
cell destruction is caused by the systemic activation of a similar extremely sensitive test system (Pyra et al.,
autoreactive T cells due to the expression of a superanti- 1994). However, using a modified version (Weissmahr
gen encoded by an endogenous retrovirus (HERV-K) on et al., 1997) of the RU5-PCR approach published pre-
the surface of antigen-presenting cells (Conrad et al., viously (LoÈ wer et al., 1993), they surprisingly amplified
1997). The search for this putative superantigen had not only HTDV/HERV-K sequences in the IDDM particle
been initiated by the observation of a pancreatic enrich- fractions but also a variety of other HERV-K families
such as an element identified in the complement (C4)ment of the Vb7 family of T cell receptor chains in two
